tirzepatide surpass trials Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the Clinical Trial Program | Cardiovascular Diabetology Full article: An update on

Qualifications for Zepbound include a BMI of 27-29.9 with a weight related comorbidity (hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea or cardiovascular disease) or a BMI of 30 or greater without a weight related comorbidity

That is a weight-loss story, and at first glance it has nothing to do with bulking

In large trials, patients lost an average of 15%21% of their body weight over time, even without intensive lifestyle changes

This article covers the specific rules for taking Zepbound (tirzepatide) when you are behind schedule, the safety limits you must follow, and how to get back into your routine without unnecessary stress